Averitas Pharma, Inc.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy (NCT06495424) | Averitas Pharma, Inc. | 2025-03-14 |
| Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery (NCT04967664) | Averitas Pharma, Inc. | 2021-07-13 |
Track Averitas Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.